Disclosure Statement
It is the policy of the Annenberg Center for Health Sciences to ensure fair balance,
independence, objectivity, and scientific rigor in all programming. All individuals with the
potential to impact the content of an accredited education activity are expected to identify and
reference off-label product use and disclose relationships with ACCME-defined ineligible
companies.
The Annenberg Center for Health Sciences assesses relevant relationships with its instructors,
planners, managers, and other individuals who are in a position to control the content of CE
activities. All relevant relationships that are identified are thoroughly vetted by the
Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity,
and patient care recommendations. The Annenberg Center is committed to providing its learners
with high-quality CE activities and related materials that promote improvements or quality
in healthcare and not a specific proprietary business interest of a commercial interest.
In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel
documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the
following disclosures have been made:
Disclosures
Caroline Apovian, MD, FACP, FTOS, DABOM Advisory Board: AbbVie Inc, Altimmune, Inc, Arrowhead Pharmaceuticals, Inc, BioAge, Biolinq Incorporated, Caribou Biosciences, Inc, CinFina Pharma, Inc, Covidien LP, Cowen and Company, LLC, Currax Pharmaceuticals, LLC, EPG Communication Holdings Ltd, Form Health, Inc, Fractyl Health, Inc, Keros Therapeutics, Inc, Lilly USA, LLC, L-Nutra, Inc, Mediflix Inc, NeuroBo Pharmaceuticals, Inc, Neurocrine Biosciences, Inc, NodThera Limited, Novo Nordisk, Nutrisystem, OptumRx, Inc, Pain Script Corporation, Palatin Technologies, Inc, Pursuit By You, Redesign Health Inc, ReShape Lifesciences Inc, Riverview School, Roman Health Ventures Inc, Scholar Rock, Inc, Terns, Inc, Verily Life Sciences LLC, Veru Inc, Vida Health, Inc, Wave Life Sciences, Wondr Health, Xeno Biosciences, ZyVersa Therapeutics, Inc.
Research Support: GI Dynamics, Inc, PCORI
Robert Kushner, MD, MS, FACP, FTOS, DABOM Advisory Board: Antag, Currax, Novo Nordisk, Structure, Weight Watchers
Consultant: Altimmune, Boehringer Ingelheim, Eli Lilly, Regeneron
The faculty for this enduring activity has disclosed that there will be
no
discussion about the use of products for non-FDA approved applications.
Additional Content Planners
Jennifer Champagne, PharmD, BCPS (Medical Writer)No significant relationships to disclose.
Eugene Cullen, MD (Peer Reviewer)No significant relationships to disclose.
Amber Lambert, MSN, FNP-C, DNP (Nurse Reviewer)No significant relationships to disclose.
All other individuals in a position to control the content of this CE activity have no relevant financial relationships to disclose.
All of the financial relationships listed for these individuals have been mitigated.
The ideas and opinions presented in this educational activity are those of the faculty and do not
necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational
activities, we encourage practitioners to use their own judgment in treating and addressing the
needs of each individual patient, taking into account that patient's unique clinical situation.
The Annenberg Center disclaims all liability and cannot be held responsible for any problems
that may arise from participating in this activity or following treatment recommendations
presented.
This activity is supported by an educational grant from Novo Nordisk Inc.
This activity is an online enduring material. Successful completion is achieved by reading
and/or viewing the material,
reflecting on its implications in your practice, and completing the assessment
component.
The estimated time to complete the activity is
1.25 hours.
This activity was originally released on
2022-03-31 and is eligible for credit through
2023-03-31.
Our Policy on Privacy
Annenberg Center for Health Sciences respects your privacy. We don’t share information you
give us, or have the need to share this information in the normal course of providing the
services and information you may request. If there should be a need or request to share this
information, we will do so only with your explicit permission. See Privacy Statement and other
information at https://annenberg.net/pages/privacyPolicy.php
Contact Information
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
[email protected]
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM,
Pacific Time, Monday – Friday
